Article Details
Retrieved on: 2024-12-30 18:14:24
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Ikena Oncology (IKNA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects.
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here